ARMP
Armata Pharmaceuticals Inc
3.60$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2,200.0% | -60.9% | +700.0% | -5.6% | +67.7% | +65.6% | +2.4% | -27.2% | -31.4% | -28.8% | +43.5% | +4.7% | -15.6% | +39.6% | -99.0% | +453.3% | -51.1% | +25.8% | +16.1% | -45.3% | -55.8% | -100.0% | – | +2,554.8% | +443.6% | +23.1% | -17.8% | +14.2% | -5.2% | |
| – | – | – | – | – | – | – | -20.9% | -42.2% | +0.5% | +5.3% | -20.4% | +22.3% | -14.3% | -19.8% | – | – | – | – | – | – | +1.4% | +261.2% | +0.0% | +969.1% | +38.6% | +75.0% | -97.2% | +3,441.8% | -95.6% | |
| – | +180.0% | -40.5% | +252.0% | -4.5% | +56.9% | +43.3% | -155.2% | – | -31.4% | -28.8% | +43.5% | +4.7% | -15.6% | – | – | – | -63.4% | +68.3% | +16.1% | -122.9% | – | – | – | – | – | – | – | -922.4% | – | |
| – | +40.2% | +13.0% | +2.3% | +7.5% | +35.0% | +63.3% | -6.8% | -41.5% | +0.5% | +5.3% | -20.4% | +22.3% | -14.3% | – | – | +108.5% | +339.3% | -10.7% | -31.2% | +42.2% | -49.3% | +69.8% | +100.8% | +47.0% | +38.6% | +75.0% | -3.6% | +1.9% | -31.1% | |
| – | +26.1% | -3.4% | +7.1% | +20.0% | +58.5% | +8.7% | +130,049,875.8% | -100.0% | +21.1% | -5.1% | +1.1% | +10.1% | -17.2% | – | – | -3.7% | +86.9% | +14.2% | -2.0% | +25.4% | -9.8% | -24.9% | +62.5% | -14.0% | +4.0% | -10.2% | +56.6% | +13.2% | -5.9% | |
| – | +37.0% | +6.7% | +2.9% | +8.9% | +46.1% | -78.2% | +28.6% | -31.2% | +21.1% | -5.1% | +606.3% | -84.2% | +198.8% | -50.1% | -61.5% | +16.3% | +165.9% | +16.5% | -26.3% | +120.9% | -31.2% | -41.4% | +85.9% | -55.1% | +4.0% | -10.2% | +497.6% | -70.3% | +162.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -331.4% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +33.3% | -100.0% | – | -100.0% | – | +70.1% | +215.0% | -14.9% | -60.7% | +7.6% | -19.7% | -99.8% | -100.0% | – | – | +160.8% | +744.5% | -100.0% | – | – | – | – | – | -32.5% | -89.8% | -54.7% | +8,955.2% | +309.1% | +54.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -147.7% | – | – | – | -102.5% | – | – | – | – | – | – | – | – | – | – | |
| – | +162.6% | -45.4% | -38.7% | +206.9% | +78.5% | -43.0% | -12.5% | -37.6% | -3.9% | +34.7% | +77.0% | -52.6% | +28.5% | – | – | – | – | -185.7% | – | – | – | – | – | – | -89.9% | -145.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -147.7% | – | – | – | -102.2% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -148.3% | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.